BACKGROUND: CaSR gene is a candidate for calcium nephrolithiasis. Single-nucleotide polymorphisms (SNPs) encompassing its regulatory region were associated with calcium nephrolithiasis. AIMS: We tested SNPs in the CaSR gene regulatory region associated with calcium nephrolithiasis and their effects in kidney. SUBJECTS AND METHODS: One hundred sixty-seven idiopathic calcium stone formers and 214 healthy controls were genotyped for four CaSR gene SNPs identified by bioinformatics analysis as modifying transcription factor binding sites. Strontium excretion after an oral load was tested in 55 stone formers. Transcriptional activity induced by variant alleles at CaSR gene promoters was compared by luciferase reporter gene assay in HEK-293 and HKC-8 cells. CaSR and claudin-14 mRNA levels were measured by real-time PCR in 107 normal kidney medulla samples and compared in patients with different CaSR genotype. RESULTS: Only rs6776158 (A>G), located in the promoter 1, was associated with nephrolithiasis. Its minor G allele was more frequent in stone formers than controls (37.8% vs 26.4%, P = .001). A reduced strontium excretion was observed in GG homozygous stone formers. Luciferase fluorescent activity was lower in cells transfected with the promoter 1 including G allele at rs6776158 than cells transfected with the A allele. CaSR mRNA levels were lower in kidney medulla samples from homozygous carriers for the G allele at rs6776158 than carriers for the A allele. Claudin-14 mRNA levels were also lower in GG homozygous subjects. CONCLUSIONS: Minor allele at rs6776158 may predispose to calcium stones by decreasing transcriptional activity of the CaSR gene promoter 1 and CaSR expression in kidney tubules.
BACKGROUND:CaSR gene is a candidate for calciumnephrolithiasis. Single-nucleotide polymorphisms (SNPs) encompassing its regulatory region were associated with calciumnephrolithiasis. AIMS: We tested SNPs in the CaSR gene regulatory region associated with calciumnephrolithiasis and their effects in kidney. SUBJECTS AND METHODS: One hundred sixty-seven idiopathic calcium stone formers and 214 healthy controls were genotyped for four CaSR gene SNPs identified by bioinformatics analysis as modifying transcription factor binding sites. Strontium excretion after an oral load was tested in 55 stone formers. Transcriptional activity induced by variant alleles at CaSR gene promoters was compared by luciferase reporter gene assay in HEK-293 and HKC-8 cells. CaSR and claudin-14 mRNA levels were measured by real-time PCR in 107 normal kidney medulla samples and compared in patients with different CaSR genotype. RESULTS: Only rs6776158 (A>G), located in the promoter 1, was associated with nephrolithiasis. Its minor G allele was more frequent in stone formers than controls (37.8% vs 26.4%, P = .001). A reduced strontium excretion was observed in GG homozygous stone formers. Luciferase fluorescent activity was lower in cells transfected with the promoter 1 including G allele at rs6776158 than cells transfected with the A allele. CaSR mRNA levels were lower in kidney medulla samples from homozygous carriers for the G allele at rs6776158 than carriers for the A allele. Claudin-14 mRNA levels were also lower in GG homozygous subjects. CONCLUSIONS: Minor allele at rs6776158 may predispose to calcium stones by decreasing transcriptional activity of the CaSR gene promoter 1 and CaSR expression in kidney tubules.
Authors: S Corbetta; C Eller-Vainicher; M Filopanti; P Saeli; G Vezzoli; T Arcidiacono; P Loli; M L Syren; L Soldati; P Beck-Peccoz; A Spada Journal: Eur J Endocrinol Date: 2006-11 Impact factor: 6.664
Authors: Hakan R Toka; Khaldoun Al-Romaih; Jacob M Koshy; Salvatore DiBartolo; Claudine H Kos; Stephen J Quinn; Gary C Curhan; David B Mount; Edward M Brown; Martin R Pollak Journal: J Am Soc Nephrol Date: 2012-09-20 Impact factor: 10.121
Authors: Tilman Breiderhoff; Nina Himmerkus; Marchel Stuiver; Kerim Mutig; Constanze Will; Iwan C Meij; Sebastian Bachmann; Markus Bleich; Thomas E Willnow; Dominik Müller Journal: Proc Natl Acad Sci U S A Date: 2012-08-13 Impact factor: 11.205
Authors: G Vezzoli; I Baragetti; S Zerbi; A Caumo; L Soldati; P Bellinzoni; A Centemero; A Rubinacci; G Moro; G Bianchi Journal: Clin Chem Date: 1998-03 Impact factor: 8.327
Authors: G Vezzoli; A Terranegra; T Arcidiacono; R Biasion; D Coviello; M L Syren; V Paloschi; S Giannini; G Mignogna; A Rubinacci; A Ferraretto; D Cusi; G Bianchi; L Soldati Journal: Kidney Int Date: 2007-02-28 Impact factor: 10.612
Authors: Naibedya Chattopadhyay; Stephen J Quinn; Olga Kifor; Chianping Ye; Edward M Brown Journal: Biochem Pharmacol Date: 2007-04-27 Impact factor: 5.858
Authors: V Matys; O V Kel-Margoulis; E Fricke; I Liebich; S Land; A Barre-Dirrie; I Reuter; D Chekmenev; M Krull; K Hornischer; N Voss; P Stegmaier; B Lewicki-Potapov; H Saxel; A E Kel; E Wingender Journal: Nucleic Acids Res Date: 2006-01-01 Impact factor: 16.971